Medicine-food homology substances in cardiovascular disease prevention and management

30-Second Summary

This review summarizes how medicine-food homology (MFH) substances may prevent and support treatment of cardiovascular disease through multi-target mechanisms (vascular protection, myocardial repair, gut–heart axis modulation, and risk factor control). Clinical randomized trials suggest MFH agents can enhance standard therapy with mild adverse events, but larger standardized trials and multi-omics research are needed to translate findings into precision medicine.

1-Minute Summary

3-Minute Summary

Full Analysis

Health Implications

Key Findings